A pelvic mesh manufacturer moved to halt a bellwether trial next month after an online news article reported that a federal judge implied the company should settle nearly 10,000 lawsuits against it.
C.R. Bard Inc. is one of seven manufacturers facing lawsuits alleging that the devices, which are implanted in women to treat pelvic organ prolapse and urinary incontinence, have caused pain and required subsequent surgeries to remove them. Bard is set to go to trial on Feb. 18 against an Ohio woman who had its Avaulta device implanted in 2007.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
